Neuburgh Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $22.9M | Sell |
671,065
-132,127
| -16% | -$4.5M | 0.71% | 33 |
|
|
2019
Q2 | $33M | Sell |
803,192
-73,930
| -8% | -$3.04M | 1.06% | 20 |
|
|
2019
Q1 | $35.3M | Buy |
877,122
+66,619
| +8% | +$2.68M | 1.2% | 19 |
|
|
2018
Q4 | $33.6M | Buy |
810,503
+81,993
| +11% | +$3.4M | 1.32% | 15 |
|
|
2018
Q3 | $30.5M | Buy |
728,510
+59,309
| +9% | +$2.48M | 0.98% | 23 |
|
|
2018
Q2 | $23M | Buy |
669,201
+28,059
| +4% | +$966K | 0.77% | 33 |
|
|
2018
Q1 | $21.6M | Buy |
641,142
+73,141
| +13% | +$2.46M | 0.76% | 36 |
|
|
2017
Q4 | $19.5M | Buy |
568,001
+107,437
| +23% | +$3.69M | 0.7% | 38 |
|
|
2017
Q3 | $15.6M | Buy |
460,564
+75,900
| +20% | +$2.57M | 0.58% | 44 |
|
|
2017
Q2 | $12.3M | Buy |
384,664
+83,857
| +28% | +$2.67M | 0.46% | 57 |
|
|
2017
Q1 | $9.76M | Buy |
300,807
+88,765
| +42% | +$2.88M | 0.39% | 57 |
|
|
2016
Q4 | $6.53M | Buy |
+212,042
| New | +$6.53M | 0.29% | 73 |
|